NASDAQ: LXEOLexeo Therapeutics Revenue
Lexeo Therapeutics revenue was $0.00 for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q1 2025) ending on Mar 31, 2025 was $0.0, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, LXEO annual revenue was $0.0, with N/A growth year-over-year.
LXEO past revenue growth
How has LXEO's revenue growth performed historically?
Company
N/A
Industry
1,675.38%
Market
37.92%
LXEO's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
LXEO's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
LXEO revenue history
Current Revenue
$0.0
Current Earnings
-$109.3M
Current Profit Margin
0%
Be the first to know when LXEO announces revenue.
LXEO Revenue History By Year
| LXEO Yearly Revenue | LXEO Revenue | LXEO Change | LXEO Revenue Growth |
|---|---|---|---|
| 2024-12-31 | $0.00 | N/A | N/A |
| 2023-12-31 | $0.00 | -$654.00k | -100.00% |
| 2022-12-31 | $654.00k | -$1.00M | -60.53% |
| 2021-12-31 | $1.66M | N/A | N/A |
Lexeo Therapeutics Revenue FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.